Search research articles
Contact Us
Filters
Showing results (111-120 of 124) with videos related to
Page
of 13
Sort By:
European Urology Oncology
|
October 10, 2022
Three-dimensional Model-assisted Minimally Invasive Partial Nephrectomy: A Systematic Review with Meta-analysis of Comparative Studies
Federico Piramide, Karl-Friedrich Kowalewski, Giovanni Cacciamani, et al.
European Urology Open Science
|
October 4, 2021
New Ultra-minimally Invasive Surgical Treatment for Benign Prostatic Hyperplasia: A Systematic Review and Analysis of Comparative Outcomes
Enrico Checcucci, Alessandro Veccia, Sabrina De Cillis, et al.
European Urology Focus
|
January 22, 2023
Salvage Radical Prostatectomy for Recurrent Prostate Cancer Following First-line Nonsurgical Treatment: Validation of the European Association of Urology Criteria in a Large, Multicenter, Contemporary Cohort
Giorgio Calleris, Giancarlo Marra, Nicole Benfant, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology
|
September 19, 2019
Robotic partial nephrectomy versus radical nephrectomy in elderly patients with large renal masses
Alessandro Veccia, Paolo Dell'oglio, Alessandro Antonelli, et al.
The Journal of Urology
|
April 4, 2022
Outcomes of Lymph Node Dissection in Nephroureterectomy in the Treatment of Upper Tract Urothelial Carcinoma: Analysis of the ROBUUST Registry
Kevin Hakimi, Umberto Carbonara, Hooman Djaladat, et al.
European Urology Focus
|
January 1, 2023
Corrigendum re "A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)" [Eur Urol Focus 2022;8:173-81]
Zhenjie Wu, Qi Chen, Hooman Djaladat, et al.
Clinical Genitourinary Cancer
|
June 10, 2023
Impact of Variant Histology on Oncological Outcomes in Upper Tract Urothelial Carcinoma: Results From the ROBUUST Collaborative Group
Antoin Douglawi, Alireza Ghoreifi, Umberto Carbonara, et al.
Minerva Urology and Nephrology
|
April 4, 2025
Should every randomized controlled trial be considered Level 1 evidence?
Bernardo Rocco, Maria C Sighinolfi, Alessandro Antonelli, et al.
European Urology Focus
|
February 7, 2021
A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)
Zhenjie Wu, Qi Chen, Hooman Djaladat, et al.
Journal of Endourology
|
January 12, 2022
Robotic <i>vs</i> Laparoscopic Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multicenter Propensity-Score Matched Pair "tetrafecta" Analysis (ROBUUST Collaborative Group)
Alessandro Veccia, Umberto Carbonara, Hooman Djaladat, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 124) with videos related to
Sort By:
Page
of 13
European Urology Oncology
|
October 10, 2022
Three-dimensional Model-assisted Minimally Invasive Partial Nephrectomy: A Systematic Review with Meta-analysis of Comparative Studies
Federico Piramide, Karl-Friedrich Kowalewski, Giovanni Cacciamani, et al.
European Urology Open Science
|
October 4, 2021
New Ultra-minimally Invasive Surgical Treatment for Benign Prostatic Hyperplasia: A Systematic Review and Analysis of Comparative Outcomes
Enrico Checcucci, Alessandro Veccia, Sabrina De Cillis, et al.
European Urology Focus
|
January 22, 2023
Salvage Radical Prostatectomy for Recurrent Prostate Cancer Following First-line Nonsurgical Treatment: Validation of the European Association of Urology Criteria in a Large, Multicenter, Contemporary Cohort
Giorgio Calleris, Giancarlo Marra, Nicole Benfant, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology
|
September 19, 2019
Robotic partial nephrectomy versus radical nephrectomy in elderly patients with large renal masses
Alessandro Veccia, Paolo Dell'oglio, Alessandro Antonelli, et al.
The Journal of Urology
|
April 4, 2022
Outcomes of Lymph Node Dissection in Nephroureterectomy in the Treatment of Upper Tract Urothelial Carcinoma: Analysis of the ROBUUST Registry
Kevin Hakimi, Umberto Carbonara, Hooman Djaladat, et al.
European Urology Focus
|
January 1, 2023
Corrigendum re "A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)" [Eur Urol Focus 2022;8:173-81]
Zhenjie Wu, Qi Chen, Hooman Djaladat, et al.
Clinical Genitourinary Cancer
|
June 10, 2023
Impact of Variant Histology on Oncological Outcomes in Upper Tract Urothelial Carcinoma: Results From the ROBUUST Collaborative Group
Antoin Douglawi, Alireza Ghoreifi, Umberto Carbonara, et al.
Minerva Urology and Nephrology
|
April 4, 2025
Should every randomized controlled trial be considered Level 1 evidence?
Bernardo Rocco, Maria C Sighinolfi, Alessandro Antonelli, et al.
European Urology Focus
|
February 7, 2021
A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)
Zhenjie Wu, Qi Chen, Hooman Djaladat, et al.
Journal of Endourology
|
January 12, 2022
Robotic <i>vs</i> Laparoscopic Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multicenter Propensity-Score Matched Pair "tetrafecta" Analysis (ROBUUST Collaborative Group)
Alessandro Veccia, Umberto Carbonara, Hooman Djaladat, et al.
Page
of 13